Mofid A, Seyyed Alinaghi SA, Zandieh S, Yazdani T.
Int J Clin Pract. 2008 Mar;62(3):433-43. doi: 10.1111/j.1742-1241.2007.01621.x. Epub 2007 Dec 11.
PMID:18081798
Hyperandrogenism drives ovarian inflammation and pyroptosis: A possible pathogenesis of PCOS follicular dysplasia.
Xiang Y, Wang H, Ding H, Xu T, Liu X, Huang Z, Wu H, Ge H.
Int Immunopharmacol. 2023 Dec;125(Pt A):111141. doi: 10.1016/j.intimp.2023.111141. Epub 2023 Oct 31.
PMID:37918087
Postmenopausal hyperandrogenism.
Yoldemir T.
Climacteric. 2022 Apr;25(2):109-117. doi: 10.1080/13697137.2021.1915273. Epub 2021 May 14.
PMID:33988479
Prenatal Testosterone Exposure Disrupts Insulin Secretion And Promotes Insulin Resistance.
Carrasco A, Recabarren MP, Rojas-García PP, Gutiérrez M, Morales K, Sir-Petermann T, Recabarren SE.
Sci Rep. 2020 Jan 15;10(1):404. doi: 10.1038/s41598-019-57197-x.
PMID:31941959
1,25-Dihydroxyvitamin D3 increases testosterone-induced 17beta-estradiol secretion and reverses testosterone-reduced connexin 43 in rat granulosa cells.
Hyperandrogenism after menopause: diagnostic evaluation.
Fux-Otta C, Torre D, Chedraui P, Melgarejo B, Ramos N, Carlo MD, Benzi M, Banús V, Estario ME, Leiderman S, Gecchelin R, Bartolacci I, Tarletta M, Ziperovich C, Lella SD, Aramayo C, Martín L, Pereyra C, Real C, Dogliani P, Ñañez M, López M, Iraci G, Fernández G; Writing Group for the Argentinian Association of Menopause and Andropause (AAMA).
Climacteric. 2025 Feb;28(1):61-68. doi: 10.1080/13697137.2024.2423874. Epub 2024 Nov 14.